INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXHNEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nyxoah S.A. (“Nyxoah” or the “Company”) (
NASDAQ: NYXH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025
Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceNyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle EastNyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle EastFirst patient implanted with Genio at Saudi German Hospital in Dubai, United Arab Emirates
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in EnglandNyxoah Announces Commercial Launch of Genio® Innovative Therapy in EnglandFirst patients implanted with Genio at UCLH, London
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nyxoah Appoints John Landry as Chief Financial OfficerNyxoah Appoints John Landry as Chief Financial Officer
Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024
DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational UpdateDREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational Update
Nyxoah to Participate in Upcoming Investor ConferencesNyxoah to Participate in Upcoming Investor Conferences
